JOURNAVX bottle and tablet (Photo: Business Wire) The Food and Drug Administration has approved suzetrigine for the treatment of moderate to severe acute pain, a new selective… by davideownzall
It does but they didnt explain. It’s the reduced impact on a person’s brain that makes it less addictive by only blocking pain receptors at periphery locations and not in the brain. Removing the feeling of being high that opiates provide and just numbs the pain.
Journavx, which has been clinically proven to be as effective as opioids in the treatment of acute post-operative pain but with a significantly more favorable side effect profile. The drug blocks pain signals that are only found in the periphery, not in the brain, without the limitations of currently available therapies.
It does but they didnt explain. It’s the reduced impact on a person’s brain that makes it less addictive by only blocking pain receptors at periphery locations and not in the brain. Removing the feeling of being high that opiates provide and just numbs the pain.